Posted in | News

Mascoma and DOE Sign Cooperative Agreement For Developing Kinross Project

Mascoma, a developer of renewable fuels, has entered into a cooperative agreement with the US Department of Energy (DOE) to financially support the design, building and functioning of a business-scale hardwood cellulosic ethanol plant in Kinross, Michigan.

According to the cooperative agreement, in addition to the contribution of $20 million, the US DOE will fund about $80 million to the development and research of the Kinross ethanol plant. Valero Energy and the State of Michigan will grant the balance fund, which is required for completing this project.

Bill Brady, Mascoma’s Chief Executive Officer and President, stated that the financial support from US DOE for the development and building of the 20 Mgal/d cellulosic ethanol plant in Kinross creates a significant milestone to the company and biofuels market. Brady added that the company is delighted to deploy the consolidated bioprocessing (CBP) technology solution to manufacture cellulosic ethanol, which serves as a less-expense, sustainable alternative to the petroleum products.

The company’s Kinross plant will employ its CBP technology solution for producing the cellulosic ethanol from the hardwood pulpwood, which is a naturally regenerated feedstock. The development and building of the project is expected to commence in the next 3 to 6 months, so that it will be completed by the end of 2013. The Kinross ethanol plant will be developed and functioned by a joint venture, Kinross Cellulosic Ethanol LLC created by Valero and Mascoma.

Valerie Reed, US DOE Office of Energy Efficiency and Renewable Energy’s Acting Biomass Program Manager, stated that in addition to the reduction of the foreign oil demands, the biofuels having increased potential ensuring new economic opportunities and jobs for rural communities in America. Reed added that cooperative agreement between the DOE and Mascoma for the development of the Kinross ethanol plant using CBP techniques will satisfy the energy demand in America with the sustainable bioprocesses.

Source: http://www.mascoma.com

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 22). Mascoma and DOE Sign Cooperative Agreement For Developing Kinross Project. AZoBuild. Retrieved on November 22, 2024 from https://www.azobuild.com/news.aspx?newsID=14709.

  • MLA

    Scanlon, Joel. "Mascoma and DOE Sign Cooperative Agreement For Developing Kinross Project". AZoBuild. 22 November 2024. <https://www.azobuild.com/news.aspx?newsID=14709>.

  • Chicago

    Scanlon, Joel. "Mascoma and DOE Sign Cooperative Agreement For Developing Kinross Project". AZoBuild. https://www.azobuild.com/news.aspx?newsID=14709. (accessed November 22, 2024).

  • Harvard

    Scanlon, Joel. 2019. Mascoma and DOE Sign Cooperative Agreement For Developing Kinross Project. AZoBuild, viewed 22 November 2024, https://www.azobuild.com/news.aspx?newsID=14709.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.